Cell-free artificial liver support: Design of appropriate clinical studies

Therapeutic Apheresis and Dialysis

Volumn 10, Issue 2, 2006, Pages 175-179

  Bernal, William ^a   Wendon, Julia ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Clinical trials; Critical care; Life support care; Liver failure; Methodology

Indexed keywords

ARTIFICIAL LIVER; BIOARTIFICIAL LIVER; CELL FREE SYSTEM; HEMOFILTRATION; HEMOPERFUSION; INTENSIVE CARE; LIVER FAILURE; LIVER SUPPORT; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

BIOMEDICAL RESEARCH; CLINICAL TRIALS; GUIDELINES; HUMANS; LIVER FAILURE; LIVER, ARTIFICIAL; RESEARCH DESIGN; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 33646253676     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2006.00360.x     Document Type: Review

References (36)

1. Aggarwal A Ong J Younossi Z Nelson D Hoffman-Hogg L Arroliga A Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU Chest 2001 119 1489 97
2. Wehler M Kokoska J Hahn E Strauss R Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems Hepatology 2001 24 255 61
3. Bernal W Wendon J Liver transplantation in adults with acute liver failure J Hepatol 2004 40 192 7
4. Lui J Gluud L Als-Nielsen B Gluud C Artificial and Bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol Liver Int 2002 22 433 8
5. Schulz K Chalmers I Hayes RJ Altman DG Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials J Am Med Assoc 1995 273 408 12
6. Altman DG Schulz KF Moher D et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration Ann Intern Med 2001 134 663 94
7. Altman D Practical Statistics for Medical Research London Chapman & Hall 1991 440 76
8. Bridgman S Engebretsen L Dainty K Kirkley A Maffulli N ISAKOS Scientific Committee Practical aspects of randomization and blinding in randomized clinical trials Arthroscopy 2003 19 1000 6
9. Kunz R Oxman A The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials BMJ 1988 317 1185 90
10. Ioannidis J Haidich A-B Pappa M et al. Comparison of evidence of treatment effects in randomized and non-randomized studies JAMA 2001 286 821 30
11. O'Grady JG Gimson AE O'Brien CJ Pucknell A Hughes RD Williams R Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure Gastroenterology 1988 94 1186 92
12. Moher D Dulberg C Wells G Statistical power, sample size and their reporting in clinical trials JAMA 1994 272 122 4
13. Freiman J Chalmers T Smith H Kuebler R The importance of beta, the type II error and sample size in the design and interpretation of the randomized controlled trial. A survey of 71 'negative' trials N Engl J Med 1978 299 690 4
14. Sen S Jalan R Williams R Extracorporeal albumin dialysis in acute on chronic liver failure: will it stand the test of time? Hepatology 2002 36 1014 16
15. Hayes P Lee A What progress with artificial livers? Lancet 2001 358 1286 7
16. Heemann U Treichel U Loock J et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study Hepatology 2002 36 949 58
17. Kramer L Bauer E Gendo A Madl C Gangl A Influence of hydroxy ethyl starch infusion on serum bilirubin levels in cirrhotic patients treated with artificial liver support Int J Artif Organs 2002 25 918 22
18. Sorkine P Abraham R Biderman P et al. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure Crit Care Med 2001 29 1332 6
19. Schmidt L Svendsen L Sorensen V Hansen B Larsen F Cerebral blood flow velocity increases during a single treatment with molecular adsorbents recycling system in patients with acute on chronic liver failure Liver Transpl 2001 7 709 12
20. Sen S Davies NE Mookerjee RP et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study Liver Transpl 2004 10 1109 19
21. Gines A Escorsell A Gines P et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites Gastroenterology 1993 105 229 36
22. Ferenci P Muller C Hepatic encephalopathy; treatment In Burroughs A Feagan B McDonald J eds Evidence Based Gastroenterology London BMJ Books 1999 443 55
23. Clemmesen JO Larsen FS Kondrup J Hansen BA Ott P Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration Hepatology 1999 29 648 53
24. Ong J Aggarwal A Krieger D et al. Correlation between ammonia levels and the severity of hepatic encephalopathy Am J Med 2003 114 188 93
25. Jaeschke H Gores GJ Cederbaum AI Hinson JA Pessayre D Lemasters JJ Mechanisms of hepatotoxicity Toxicol Sci 2002 65 166 76
26. Doria C Mandala L Smith J et al. Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system Clin Transpl 2004 18 365 71
27. Kramer L Gendo A Madl C et al. Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy Am J Kidney Dis 2000 36 1193 2000
28. Stange J Meta-analysis in albumin dialysis Liver Transpl 2004 10 1107 8
29. Davenport A Will EJ Davison AM Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure Kidney Int 1993 43 S245 S251
30. Hughes R Pucknell A Routley D Wendon J Williams R Evaluation of the Biologic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure Int J Artif Organs 1994 17 657 62
31. Mazariegos G Ash S Patzer J Preliminary results: randomized clinical trial of the BioLogic-DT in treatment of acute hepatic failure (AHF) with coma (abstract) Artif Organs 1997 21 529
32. Kramer L Gendo A Madl C et al. A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathy Int J Artif Organs 2001 24 434 42
33. Wilkinson AH Ash SR Nissenson AR Hemodiabsorption in treatment of hepatic failure J Transpl Coordination 1998 8 43 50
34. Ellis A Hughes R Nicholl D et al. Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the Biologic-DT Int J Artif Organs 1999 22 27 34
35. He JQ Chen CY Deng JT Qi HX Zhang XQ Chen JQ Clinical study on the treatment of fatal hepatitis with artificial liver support system Chinese Crit Care Med 2000 12 105 8
36. Mitzner S Stange J Klammt S et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial Liver Transpl 2000 6 277 86